PMID- 22342062 OWN - NLM STAT- MEDLINE DCOM- 20130507 LR - 20191210 IS - 1873-264X (Electronic) IS - 0731-7085 (Linking) VI - 73 DP - 2013 Jan 25 TI - Chiral separation of 3,4-methylenedioxymethamphetamine (MDMA) enantiomers using batch chromatography with peak shaving recycling and its effects on oxidative stress status in rat liver. PG - 13-7 LID - S0731-7085(12)00045-3 [pii] LID - 10.1016/j.jpba.2012.01.025 [doi] AB - This work reports the multimiligram separation of 3,4-methylenedioxy-methamphetamine (MDMA) enantiomers using batch chromatography with peak shaving recycling. The effect of both enantiomers compared to the racemic mixture was examined on the oxidative stress status of rat liver. The enantiomeric purification was performed using a based cyclodextrin chiral selector and methanol:ammonium acetate buffer (pH 6.0, 100mM) (30:70, v/v) as mobile phase. The average mass rate obtained was 40.0mg/day, providing 45.0mg of the (R)-(-)-MDMA (e.r. 99.0%) and 75.0mg (e.r. 96.0%) of (S)-(+)-MDMA. Racemic MDMA and both enantiomers were administered per orally to Wistar rats and oxidative stress status parameters, as liver total glutathione levels and malondialdehyde (MDA) production in liver were evaluated. There was a significant decrease in hepatic glutathione content in the racemic MDMA and the (R)-(-)-MDMA-treated rats when compared to the control and to (S)-(+)-MDMA. These results demonstrate that the R-enantiomer is the enantiomer that contributes to the depletion of hepatic glutathione induced by the racemic mixture. The high reactivity of the R-enantiomer of MDMA in the liver can also be observed in animals treated with (R)-(-)-MDMA. The production of malondialdehyde (MDA) by (R)-(-)-MDMA was significantly higher when compared to the other treated groups and control. CI - Copyright (c) 2012 Elsevier B.V. All rights reserved. FAU - Lourenco, Tiago C AU - Lourenco TC AD - Departamento de Quimica, Universidade Federal de Sao Carlos, Sao Carlos - SP, Brazil. FAU - Bosio, Graziela C AU - Bosio GC FAU - Cassiano, Neila M AU - Cassiano NM FAU - Cass, Quezia B AU - Cass QB FAU - Moreau, Regina L M AU - Moreau RL LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20120130 PL - England TA - J Pharm Biomed Anal JT - Journal of pharmaceutical and biomedical analysis JID - 8309336 RN - 0 (Illicit Drugs) RN - 4Y8F71G49Q (Malondialdehyde) RN - GAN16C9B8O (Glutathione) RN - KE1SEN21RM (N-Methyl-3,4-methylenedioxyamphetamine) SB - IM MH - Animals MH - Chromatography, High Pressure Liquid/*methods MH - Glutathione/metabolism MH - High-Throughput Screening Assays MH - Illicit Drugs/chemistry/*isolation & purification/toxicity MH - Lipid Peroxidation/drug effects MH - Liver/*drug effects/metabolism MH - Male MH - Malondialdehyde/metabolism MH - N-Methyl-3,4-methylenedioxyamphetamine/chemistry/*isolation & purification/toxicity MH - Oxidative Stress/*drug effects MH - Rats MH - Rats, Wistar MH - Stereoisomerism EDAT- 2012/02/22 06:00 MHDA- 2013/05/08 06:00 CRDT- 2012/02/21 06:00 PHST- 2011/12/07 00:00 [received] PHST- 2012/01/19 00:00 [revised] PHST- 2012/01/21 00:00 [accepted] PHST- 2012/02/21 06:00 [entrez] PHST- 2012/02/22 06:00 [pubmed] PHST- 2013/05/08 06:00 [medline] AID - S0731-7085(12)00045-3 [pii] AID - 10.1016/j.jpba.2012.01.025 [doi] PST - ppublish SO - J Pharm Biomed Anal. 2013 Jan 25;73:13-7. doi: 10.1016/j.jpba.2012.01.025. Epub 2012 Jan 30.